Categories
Health

Well being Care Employees on the Frontline Face a 12 months of Threat, Worry and Loss

Gabrielle Dawn Luna sees her father with every patient she treats.

As a nurse in the emergency room at the same hospital where her father died of Covid in March last year, Ms. Luna knows firsthand what it is like for a family to hold onto any new information. She has become aware of the need to take extra time to explain developments to a patient’s family members who are frequently checking for updates.

And Mrs. Luna was willing to share her personal loss if it helps, as she recently did with a patient whose husband has died. But she also learned to hold it back to respect each person’s grief, as she did when a colleague’s father succumbed to the disease.

It is a challenge to let oneself grieve enough to help patients without feeling overwhelmed.

“Sometimes I think it’s too much of a responsibility,” she said. “But that’s the job I signed up for, isn’t it?”

The Lunas are a foster family. Her father, Tom Omaña Luna, was also a lifeguard and was proud when Mrs. Luna came to him in the field. When he died on April 9, Ms. Luna, who also had mild symptoms of Covid-19, took about a week off. Her mother, a nurse in a long-term care facility, then spent about six weeks at home.

“She didn’t want me to go back to work for fear that something would happen to me too,” said Ms. Luna. “But I had to go back. You needed me “

As her hospital in Teaneck, New Jersey swelled with virus patients, she struggled with stress, burnout, and an excruciating fear that left an open wound on her grief: “Did I give it to him? I don’t want to think about it, but it’s a possibility. “

Like the Lunas, many who treated millions of coronavirus patients in the United States last year come from medically defined families. It is a calling that is passed down through the generations and connects spouses and siblings who are states apart.

It’s a bond that brings the success of shared experiences, but for many, the pandemic has also brought a variety of fears and stresses with it. Many have been concerned about the risks they are taking and those their loved ones are exposed to every day. They worry about the invisible scars they have left.

And for those like Ms. Luna, the care they give coronavirus patients is shaped by the beloved healer they lost to the virus.

For Dr. Nadia Zuabi is so new to the loss that she still refers to her father, another ambulance in the present.

Your father, dr. Shawki Zuabi spent his final days at her UCI Health hospital in Orange County, California before dying of Covid on January 8th. The younger Dr. Zuabi returned to work almost immediately, hoping to carry on with the purpose and camaraderie of her colleagues.

She had expected that working with the people who had cared for her father would deepen her commitment to her own patients, and to some extent, too. Most importantly, she realized how important it is to balance this stressful emotional availability with her own well-being.

“I always try to be as empathic and compassionate as possible,” said Dr. Zuabi. “There is a part of you who may have to build a wall as a survival mechanism because I don’t think it’s sustainable to feel it all the time.”

The work is filled with memories. When she saw the fingertips of a patient, she remembered how her colleagues had also pricked her father’s to check insulin levels.

“He had all these bruises on his fingertips,” she said. “It just broke my heart.”

The two had always been close, but they found a special bond when she went to medical school. Doctors often descend from doctors. About 20 percent in Sweden have parents with medical degrees, and researchers believe the rate is similar in the United States.

The older Dr. Zuabi had a present for conversation and loved talking about medicine with his daughter as he sat in his living room chair with his feet propped up. She is still in her residency training and would reach out to him all last year for advice on the challenging Covid cases she was working on and he would dispel her doubts. “You have to trust yourself,” he told her.

Updated

March 13, 2021, 6:24 p.m. ET

When he caught the virus, she took each day off to be by his bedside and continued their conversations. Even when he was intubated, she pretended they were still talking.

She still does. After difficult shifts, she turns to her memories, the part of him that stays with her. “He really thought I was going to be a great doctor,” she said. “If that’s what my father thought of me, it must be true. I can do it, even if it doesn’t feel like it sometimes. “

Just as medicine is often a passion that arises from a set of values ​​passed down from one generation to the next, so it is also one that is shared by siblings and that brings healers together in marriage.

A quarter of doctors in the US are married to another doctor, according to a study published in the Annals of Internal Medicine. Maria Polyakova, a professor of health policy at Stanford University, said she wouldn’t be surprised if the number of doctors in the U.S. who had siblings with medical degrees was about as high as the Swedish, about 14 percent.

In interviews with a dozen doctors and nurses, they described how helpful it has long been to have a loved one who knows the rigors of the job. But the pandemic has also shown how frightening it can be to put a loved one at risk.

A nurse’s brother took care of her when she had the virus before volunteering at another virus hotspot. A doctor chatted with her children about what would happen if she and her husband both died from the virus. And others described crying softly during a will talk after putting their children to bed.

Dr. Fred E. Kency Jr., a doctor at two emergency rooms in Jackson, Miss., Understood that he was surrounded by danger while serving in the Navy. He never expected that he would face such a threat in civil life or that his wife, an internist and pediatrician, would face the same dangers.

“It’s scary to know that my wife has to go to the rooms of patients with Covid every day,” said Dr. Kency before he and his wife were vaccinated. “But it is a reward to know that not just one of us, the two of us, are doing everything we can to save lives in this pandemic.”

The vaccine has eliminated fears of being vaccinated at work among vaccinated medical professionals, but some express deep concern at the toll that working in a year of horror has left their closest relatives.

“I am concerned about the amount of suffering and death she sees,” said Dr. Adesuwa I. Akhetuamhen, an emergency physician at Northwestern Medicine in Chicago, about her sister, the doctor at the Mayo Clinic in Rochester, Minn. I feel like I learned to deal with this while working in the emergency room before Covid started, but it’s not something that should be happening in her specialty as a neurologist. “

She and her sister, Dr. Eseosa T. Ighodaro, have been on the phone regularly to compare notes on the precautions they have taken, to update their families, and to support one another. “She totally understands what I’m going through and encourages me,” said Dr. Ighodaro.

The seemingly endless intensity of work, increasing deaths, and the careless attitudes of some Americans about safety precautions have caused anxiety, fatigue, and burnout in a growing number of healthcare workers. Almost 25 percent of them are most likely to have PTSD, according to a survey published by the Yale School of Medicine in February. And many have left the field or are considering doing so.

Donna Quinn, a midwife at NYU Health in Manhattan, has feared that her son’s experience as an ambulance doctor in Chicago will cause him to leave the field he recently came to. He was in his final year of residence when the pandemic started and he volunteered on the intubation team.

“I’m concerned about the toll he’s taking emotionally,” she said. “There were nights when we tearfully talked about what happened to us.”

She still has nightmares that are sometimes so terrible that she falls out of bed. Some are about her son or about patients she cannot help. In one, a patient’s bed linen is transformed into a towering monster that chases her out of the room.

When Ms. Luna first returned to her emergency room at Holy Name Medical Center in Teaneck, New Jersey after her father’s death, she felt that something was missing. She had got used to having him there. It had been nerve-wracking when she was asked, “Is that my father?” On every urgent intercom call after a resuscitation. But at least she could stop by now and then to see how he was doing.

Furthermore, she had never known what it was like to be a nurse without him. She remembered going to elementary school to step into the field and using a yellow highlighter to paint over almost every line in his large textbooks.

During breakfast last March, Ms. Luna told her father how upset she was after holding an iPad for a dying patient to say goodbye to a family who couldn’t go to the hospital.

“This is our job,” she recalled Mr. Luna. “We’re here to act as a family when the family can’t be there. It’s a difficult role. It will be difficult, and there will be more times that you have to do it. “

Kitty Bennett contributed to the research.

Categories
Health

People will collect earlier than Biden’s July four goal

Dr. Scott Gottlieb told CNBC on Friday he thinks many Americans will hold group meetings long before President Joe Biden’s goal of celebrating Independence Day.

In an interview on Squawk Box, the former Food and Drug Administration commissioner said he believed the schedule Biden set out in his prime-time speech on Thursday is too conservative compared to how people actually behaved.

“I think the majority of Americans will meet long before July,” said Gottlieb, who headed the FDA during the Trump administration from 2017 to 2019. He is now a member of the board of directors of Pfizer, which makes one of three Covid vaccines approved for emergency use in the United States

Biden’s speech on Thursday evening on the pandemic aimed to highlight the collective toll Covid has suffered over the past year while also pointing out two forward-looking public health goals. The first: instructing states to qualify all adults for coronavirus vaccines by May 1. The second: A destination for Americans to safely gather together in small groups with friends and loved ones to celebrate July Fourth.

“I think we should give public health advice that is appropriate to where people are,” Gottlieb said. “”[When] People feel that the risk is reduced because they have been vaccinated, because they see infection rates falling in many parts of the country. They will be willing to take more risks because they feel their vulnerability is decreasing. And you know what? You’re right. “He predicted,” People will be out this summer and they will be out well before July. “

In response to Gottlieb’s remarks, the White House told CNBC that the timing of the meetings was a matter for health and medical experts at the CDC.

Earlier this week, the Centers for Disease Control and Prevention issued new guidelines that allow fully vaccinated individuals to safely congregate indoors with other fully vaccinated individuals – and certain unvaccinated individuals – without masks or social distance.

The guidelines came as states in the US lifted pandemic restrictions in recent weeks as vaccinations rolled out and daily coronavirus infections fell well below their January high. However, senior health officials in the Biden administration have warned that the decline in cases is gradually easing. The competing states should be more careful about lifting capacity restrictions for companies and masking mandates.

Last Friday, Gottlieb said mask mandates should be the final guidelines states and localities repeal after Texas and Mississippi announced the end of their face-covering rules.

According to a CNBC analysis of Johns Hopkins University data, the US has recorded an average of 53,798 new cases per day for the past seven days. That’s 15% less than a week ago. The number of new U.S. cases on Thursday stood at 49,356, a decrease of nearly 84% from the record high on Jan. 2.

A key factor helping to slow the spread of the virus is the increasing immunity of the US population, Gottlieb said. He estimated that around half of the US population has some form of protective immunity against the coronavirus, taking into account both diagnosed and undiagnosed infections along with those who have been vaccinated.

Approximately 64 million Americans have received at least one dose of Covid vaccine, which is roughly 19% of the US population of 330 million people, according to the CDC. One in ten Americans is fully vaccinated.

Pfizer and Moderna vaccines, which Americans have been receiving since December, require two shots to provide full protection against the development of Covid. However, studies suggest that there is some immunity after the initial dose. Johnson & Johnson’s vaccine, the youngest entrant in the US market, is just a single shot.

The US has approximately 29.3 million confirmed coronavirus cases, according to Johns Hopkins. The real number is higher, said Gottlieb, repeating a position he has held since the beginning of the pandemic. He explains that not every infected person has been tested and their positive result recorded.

“We’re probably diagnosing one in four infections, maybe a bit better than now,” said Gottlieb, who previously estimated that about a third of Americans could have got Covid. “So we are over 50%” of the population with some form of immunity, he added.

“At this level, you won’t spread the infections as quickly. It’s not quite herd immunity, but you will get immunity in the population,” he said.

Disclosure: Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, genetic testing startup Tempus, healthcare technology company Aetion, and Illumina biotech. He is also co-chair of the Healthy Sail Panel for Norwegian Cruise Line Holdings and Royal Caribbean.

Categories
Health

Issues To Do At Residence

Cook traditional Iranian dishes with chef Louisa Shafia to celebrate Nowruz, or the Persian New Year which will be held on March 20th this year, in a class presented by the Museum of Food and Drink. Ms. Shafia, the author of “The New Persian Kitchen,” will guide viewers through the culinary traditions and rituals of the holiday as she cooked with ash reshteh, a noodle soup made with herbs, beans, fried onions and mint and fried mahi sorkh kardeh fish Turmeric and green herbs. She is also accompanied by Iranian journalist Yeganeh Rezaian in a conversation about her own Nowruz traditions, moderated by Nazli Parvizi, President of the Museum of Food and Drink. Recipes are available in advance if you want to collect ingredients and cook them at home. Tickets for this event are $ 15.

When 7 p.m. east

Where mofad.org/events/0318/nowruz

Take part in a listening party for the world premiere of “Romeo y Julieta,A bilingual Spanish and English audio adaptation of Shakespeare’s play presented by WNYC Studios, the Public Theater and Greene Space. Directed by Saheem Ali, this podcast stars Lupita Nyong’o as Julieta and Juan Castano as Romeo. WNYC presenter Rebeca Ibarra will hold a cocktail demo before the show and a live interview with the actors and director after the presentation. This event is free.

When 6:45 p.m. East

Where thegreenespace.org/event/romeo-y-julieta-world-premiere-event

Stream a virtual dance tour from Dance Rising, A group formed in response to the pandemic and its impact on the dance community. The tour features videos of more than 300 artists who participated in hyperlocal dance events in the five boroughs of New York City in 2020. The event can be streamed at any time.

When At any time

Where dancerising.org

Fight hunger and listen to music by Dan + Shay, Sara Bareilles, Jewel, Infinity Song, Darius Rucker, Daryl Hall, and others for Oates Song Fest 7908, a performance and fundraiser for Feeding America. The show is presented by John Oates of the band Hall & Oates; his wife Aimee Oates; Drive Entertainment Group; and NugsTV. Mr. Oates will host alongside the musician Saxsquatch. This event is free, but donations are accepted.

Categories
Health

WHO probing studies of blood clots in recipients

Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO), speaks after Dr. Anthony Fauci, Director of the National Institute for Allergies and Infectious Diseases, during the 148th session of the Executive Board on the Coronavirus Disease (COVID-19) outbreak in Geneva, Switzerland, January 21, 2021.

Christopher Black | WHO | via Reuters

The World Health Organization announced on Friday that it is reviewing recent reports of blood clots in some people who have received the AstraZeneca Covid-19 vaccine, which has led some countries to stop introducing the shooting.

At least nine countries, including Denmark, Norway, Iceland and Thailand, have stopped using the vaccine for safety reasons. By Wednesday, around 5 million people in Europe had received the Oxford-AstraZeneca vaccine. Of this number, 30 so-called thromboembolic events were reported in recipients. These are blood clots that form in blood vessels and block blood flow.

AstraZeneca said in a statement Friday that there is “no evidence” that the vaccine causes an increased risk of developing blood clots.

WHO director-general Tedros Adhanom Ghebreyesus said Friday that the agency’s Global Advisory Committee on Vaccine Safety “is systematically reviewing safety signals and carefully evaluating recent reports on the AstraZeneca vaccine”.

“Once WHO has a full understanding of these events,” he added, “the results and changes to our current recommendations will be communicated to the public immediately.”

Dr. Mariangela Simao, WHO deputy director general for access to medicines and health products, added that the global health agency “is likely to have a statement this next week when investigations are complete”.

“The WHO is very much aligned with the position that we should continue immunization until we have cleared up the causal link,” she said.

Dr. Soumya Swaminathan, WHO’s chief scientist, said it was still unclear whether the vaccine was actually causing the clots. An AstraZeneca spokesperson noted that “the observed number of these types of events in vaccinated people is significantly lower than expected in the general population”.

“The adverse events reported after vaccination must be seen in the context of events that occur naturally in the population,” said Swaminathan. “Just because it’s reported after a vaccination doesn’t mean it’s the vaccination. It could be completely independent.”

The European Medicines Agency, the European Medicines Agency, has stressed that there is no evidence that the AstraZeneca shot caused blood clots and that the benefits of the vaccine “continue to outweigh the risks”.

“Reports of previously received blood clots are no greater than the numbers that would have occurred naturally in the vaccinated population,” said Dr. Phil Bryan, Vaccine Safety Director for the UK Medicines and Health Products Regulatory Agency.

“Public safety will always come first. We will continue to examine this issue carefully, but the evidence available does not confirm the vaccine is the cause. People should still get their COVID-19 vaccine when prompted become.” he added.

– CNBC’s Sam Meredith contributed to this report.

Categories
Health

Can the World Be taught From South Africa’s Vaccine Trials?

In a year that has fluctuated between staggering profits and brutal setbacks at Covid-19, few moments have been as sobering as last month’s discovery that a variant of coronavirus in South Africa was dampening the effects of one of the most effective vaccines in the world.

That finding – from a South African trial with the Oxford-AstraZeneca shot – revealed how quickly the virus had managed to evade human antibodies, ending what some researchers have described as the worldwide honeymoon period with Covid-19 vaccines, and continuing that Hopes return to contain the pandemic.

As countries prepare for this difficult turnaround, the story of how scientists uncovered the dangers of the variant in South Africa has brought focus to the global vaccine trials that were essential in warning the world.

“Historically, people might have thought that a problem in a country like South Africa would remain in South Africa,” said Mark Feinberg, executive director of IAVI, a nonprofit scientific research group. “But we’ve seen how quickly variants pop up all over the world. Even wealthy countries need to pay a lot of attention to the developing landscape around the world. “

After the deliberations in the vaccine race, these global studies saved the world from sleepwalking into the second year of the coronavirus without knowing how the pathogen might weaken the body’s immune response, scientists said. They also provide lessons on how vaccine manufacturers can combat new variants and eliminate long-standing health inequalities this year.

The deck is often stacked against drug trials in poorer countries: drug and vaccine manufacturers attract their largest commercial markets, and often avoid the cost and uncertainty of testing products in the global south. Less than 3 percent of clinical trials are conducted in Africa.

However, the emergence of new varieties in South Africa and Brazil has shown that vaccine manufacturers cannot afford to wait years, as they have often done, before testing that shots work in poorer ones for rich countries.

“If you fail to identify and respond to what is happening on a supposedly distant continent, it has a significant impact on global health,” said Clare Cutland, a vaccine scientist at the Witwatersrand University in Johannesburg who coordinated the Oxford study. “These results have shown the world that there isn’t a single pathogen sitting there doing nothing – it is constantly mutating.”

Although the Oxford vaccine offers minimal protection against mild or moderate cases caused by the variant in South Africa, it will likely prevent these patients from becoming seriously ill, preventing an increase in hospitalizations and deaths. Laboratory studies have produced a mix of hopeful and more worrying results about how much the variant disrupts Pfizer and Moderna’s recordings.

Even so, vaccine manufacturers are trying to test updated booster vaccinations. And countries are trying to isolate cases of the variant that South African studies have shown could potentially re-infect humans as well.

In March of last year, long before scientists became angry about variants, Shabir Madhi, a veteran vaccinologist at the Witwatersrand University, began to persuade vaccine manufacturers to conduct trials.

Dr. Realizing how long Africa often waits for life-saving vaccines as it did with swine flu vaccinations a decade ago, Madhi wanted to quickly examine how Covid-19 vaccines work on the continent, even with people with HIV no excuse for the world the delay in permits or deliveries. Different socio-economic and health conditions can alter the performance of vaccines.

“I’m sure I can get money,” he emailed the Oxford team on March 31 last year, adding that “it would be important to evaluate in relation to HIV.”

Oxford agreed, and the Bill and Melinda Gates Foundation contributed $ 7.3 million, cementing its role as the linchpin of efforts to steer vaccine trials to the global south.

Even so, the process had to contend with difficulties that larger studies with better resources in the US and Europe did not have. On the one hand, Dr. Madhi eliminate several test sites because they did not have sufficiently cold freezers or emergency power generators. This is necessary in a country where frequent power outages can put valuable doses at risk.

Even when the researchers locked down sites and relied on clinics with experience conducting HIV studies, the study was almost rolled back. The test results showed that almost half of the earliest volunteers were already infected with the virus at the time of vaccination, invalidating their results.

Updated

March 13, 2021, 6:24 p.m. ET

“We had a limited amount of funding and a limited number of vaccines,” said Dr. Cutland. “We were very concerned that the process had completely derailed.”

At another test site, all three pharmacists have signed Covid-19 and have withdrawn the only people who are allowed to prepare shots. Nurses in the study lost siblings and parents to the disease. The staff was so overwhelmed that the phones sometimes rang when vaccine managers called from abroad.

The magnitude of the pandemic in South Africa – 51,000 people have died and up to half the population may be infected – nearly overturned the process. But that was also part of what attracted vaccine makers: More cases mean faster results.

Dr. Madhi’s team weathered the storm, working 12-hour days and adding last-minute swabs to make sure the volunteers weren’t already infected. By May, he had asked Novavax, then a little-known American company with the support of the Trump administration, to conduct a lawsuit there too. Novavax agreed, and the Gates Foundation raised $ 15 million. However, the process was not registered until a few months later.

Novavax said the process took some time. However, the delay also reflected what scientists have called pressure on American-backed vaccine manufacturers to focus their efforts on the United States. Studies there are the best way to unlock coveted approvals from the Food and Drug Administration, the world’s gold standard drug agency.

And vaccine manufacturers tend to know their largest markets best.

“Companies have the greatest experience of clinical trials in parts of the world that represent their commercial markets,” said Dr. Feinberg.

For vaccine manufacturers who have made supplying the world a core part of their strategies, the trials have been a boon. Novavax showed that the effectiveness of the vaccine was only moderately weakened by the variant in South Africa. Johnson & Johnson, who also conducted a South African study, showed that their vaccine was protected from hospitalization and death there.

What you need to know about the vaccine rollout

“You have your fishing line in the water – and by the time we were there the virus developed,” said Dr. Gregory Glenn, President of Research and Development at Novavax. “This is invaluable data for us and the world.”

In a recent laboratory study, the Oxford-AstraZeneca vaccine protected hamsters exposed to the variant from disease, even when the animals’ immune responses were slightly weaker. The human study in South Africa was too small to be able to say definitively whether the vaccine prevents serious diseases. Finding that it offers minimal protection from milder cases was itself daunting, as the shot remains the backbone of the introduction of many poorer countries.

In South Africa, the results failed because of plans to give the Oxford vaccine to health workers. Despite the implementation of trials, the country was unable to use them for early purchase agreements and delayed deliveries. Only a fifth of 1 percent of the people there have been vaccinated, raising fears of another wave of deaths and further mutations.

If HIV research laid the groundwork for vaccine trials in South Africa, some scientists hope that an explosion in global studies on the pandemic will show drug companies that other countries have the infrastructure to conduct larger studies.

To this end, the Gates-supported Coalition for Epidemic Preparedness Innovations offers companies incentives to conduct further Covid-19 vaccine trials in poorer countries.

“People tend to go for what they know,” said Melanie Saville, the coalition’s director of vaccine research and development. “However, in low- and middle-income countries, capacity is increasing and we need to encourage developers to use it.”

Large numbers of South Africans volunteered for the trials. Most mornings, Dr. Anthonet Koen, who operated a location in Johannesburg for the Oxford and Novavax processes, opened their doors at 6 a.m. At this point, the participants had already been outside for two hours.

On December 11th, Dr. Koen that the pandemic was increasing: After weeks without a case, two people in the study tested positive. Then more and more every day. Health officials announced the discovery of the variant a week later. The random placement of the studies gave the scientists what they almost never had: an open-air laboratory where they could watch in real time how a vaccine and a variant stood in front of them.

Since the Oxford results were announced last month, volunteers have tried to comfort them, said Dr. Koen: “I get a lot of condolences and ‘I’m sorry’,” she said.

As long as this vaccine prevents and other serious diseases, the world can live with the virus even in cases of the variant, scientists said. However, the trial in South Africa underscored the need to eradicate the virus before it mutates further. Without them, scientists said, the world could have been blind to what was to come.

“We would assume that these variants are not the end of the story,” said Andrew Pollard, the Oxford scientist responsible for his experiments. “For the virus to survive, it must continue to mutate once the populations have good immunity to the current variants.”

Categories
Health

Sanofi CEO on navigating Covid one yr later. Now what?

A laboratory technician, who works on vaccine formulation and wears personal protective equipment, prepares stainless steel tanks for the manufacture of vaccine preparations before the syringe filling phase in the global distribution center of a French pharmaceutical company Sanofi in Val-de-Reuil.

Joel Saget | AFP via Getty Images

Paul Hudson is the CEO of Sanofi. The French pharmaceutical company has two Covid-19 vaccines in development – one with GlaxoSmithKline and one with Translate Bio for an mRNA vaccine. It also makes vaccine doses for competitors Johnson & Johnson and Pfizer.

As the one-year anniversary of the first lockdowns around the world begins, it is clear that the Covid-19 pandemic is still going on and staying here.

To date, the virus has killed over 2.5 million people and infected millions more worldwide. While vaccines give us hope, we face new challenges as different varieties spread around the world that challenge the effectiveness of currently approved vaccines. As the virus mutates, there is a realization that Covid-19 could move from a pandemic to an endemic one and this is becoming a ubiquitous disease that will stay with us for the foreseeable future. However, now we know how to deal with it.

We need to adjust our thinking from the time the virus disappears to learning how to deal with it so that it becomes less threatening. How do we successfully navigate the road instead of looking for the light at the end of the tunnel? It won’t be easy, but we can do it through variant preparation, continued genome monitoring, data mining and analysis, and purpose-driven collaboration.

Willingness to vary

First, we should assume that Covid-19 will not go away. Although this thought can be unsettling, it is a reminder that we need to be prepared for ongoing boosters in order to receive new variants such as Great Britain (B.1.1.7), South Africa (B.1.351), Brazil (P.1) or prevent a completely new variant from being circulated and taking more life.

First Covid-19 vaccines have already proven successful in limiting the spread of disease. However, there are concerns that if we don’t vaccinate quickly enough, we will not be able to keep up with the pace of virus mutations and variants could gain a foothold in the community and cause new outbreaks. Research is still being conducted into how current vaccines protect against variants and whether annual vaccination might be required, similar to the one for the influenza virus.

Our first priority is to get everyone vaccinated around the world. We need to develop boosters at the same time to address mutations as needed. Several manufacturers with vaccines in the market are already evaluating annual booster vaccinations to maintain immunity and treat variants after the first two doses are given.

As with the influenza virus, we need to consider the potential need for vaccines with multiple variants. Covid-19 has been mutating all along, and although we have identified several key strains, there are hypotheses that viral mutations that offer an advantage in transmission may evade the protection of naturally acquired or vaccine-induced immunity. However, this also underscores the importance of multiple vaccine manufacturers as those still in clinical development can customize their vaccines to ensure that their candidates can protect against important new mutations.

Genomic surveillance

To better track variants, governments and healthcare companies need to invest in genome monitoring infrastructure by working with technology companies to identify mutations in the virus. Variations are inevitable, but we need this infrastructure in place to quickly identify mutations and spread this data globally to quickly control the spread.

The UK is the world leader in virus sequencing, collecting nearly 4 million virus samples. Thanks to the country’s regular testing and genome sequencing capabilities, they were able to detect the B.1.1.7 variant of the virus, which otherwise might have gone unnoticed. To ensure this data is widely available, the UK is placing its genomes in the global library initiative to share all influenza data. As of January 29, the country has submitted 44% of the genomes in the library.

Data mining and analysis

While genomic testing infrastructure is required to identify new mutations, that effort is minimal if we do not use data and analysis for our health and vaccine systems. In this way, we can improve our logistics for both the distribution and administration of vaccines, and we can quickly track and overcome hot spots.

Analytics companies and startups are using health data mining to anticipate the next Covid-19 hotspots so that health systems not only prepare for vaccines, but potentially make decisions about giving advice to risk groups and reintroducing non-pharmaceuticals Products can expect interventions, ensuring adequate supplies of PPE, medication and health equipment.

Mayo Clinic researchers used data to analyze keywords from Google Trends, including “face mask”, “Lysol” and “test center”. They found that these searches can identify a new hot spot or outbreak up to 16 days before the first report of a spike in cases. With this information, governments can monitor Google Search to better track the spread digitally, and then use it to strategically distribute PPE supplies or redirect funds to areas that need it most – before cases even start to rise .

Purposeful actions

Cooperation during the Covid-19 pandemic has taken place at an unprecedented level. Corporations, governments and regulators have moved at an incredible pace to approve the necessary therapies and vaccines for patients. Former competitors are now working together to bring the needs of patients and the world’s population to the fore. However, in order to bring about a meaningful change, these measures must be purpose-oriented.

We’re working with traditional competitors to make their vaccines so we can get more doses into patients’ arms faster. We didn’t hesitate to help, and other companies should step in and help too. We must act purposefully and put aside “competition” in order to do what is best for humanity.

If we don’t swear to overhaul our old systems, we risk reverting to these outdated methods. Other large companies outside the pharmaceutical industry can also help. Take, for example, companies like Walmart, Starbucks, Microsoft, and Amazon that are working with local governments and healthcare providers in the United States to increase vaccine distribution. Some companies like CVS, Walgreens, and others have experience serving hundreds of thousands of customers on a given day and have the expertise needed to enable vaccines to vaccinate patients quickly and efficiently.

The pandemic is constantly changing the way we work. If we learn to live with Covid-19, we need to accelerate our pace and find new ways to work together. Most of all, we need to move forward in a focused manner and work with traditional competitors and non-traditional partners to do the right thing.

Categories
Health

Alabama Might Enable Yoga in Public Colleges After a 28-Yr Ban

Mr. Gray indicated that his bill would allow schools and students to make their own decisions about whether to offer or attend yoga classes. It is also said that public school teachers cannot say “namaste,” a greeting often used in yoga, or any type of chant.

“You have to compromise to get this bipartisan support,” he said.

Most of the time, Mr. Gray encountered the problem by accident. In a speech at a public high school in Auburn, Ala., In 2019, he mentioned that yoga had helped him keep grounded while juggling responsibilities.

After he explained, the teachers informed him that they could not arrange exercises for their students. “That’s how I learned it was banned,” said Mr. Gray.

Around the time of the ban in 1993, the state’s parents raised concerns not only about yoga, but also about hypnosis and “psychotherapeutic techniques.” According to an April 1993 article in The Anniston Star, a mother in Birmingham said her child brought home a relaxation tape that made a boy “visibly high,” The Montgomery Advertiser reported.

But for Mr. Gray, a former soccer player, yoga has long been a useful part of his training schedule. The gentle stretches helped him cool off after a workout, while the breathing exercises strengthened his lungs. (That, he added, may have helped him recover quickly from a Covid-19 attack last year.)

He put his first bill to challenge the yoga ban in 2019, but it quickly failed. His second attempt passed the house in 2020, but was pushed into the background because of the pandemic.

This time Mr. Gray is optimistic about the bill’s prospects. He said a Republican Senator, Tom Whatley, has agreed to drive legislation in the Senate, where Republicans like the House have a majority. (Mr. Whatley didn’t immediately respond to an email asking for comment on Friday.)

Categories
Health

Dentists, veterinarians and med college students licensed to manage pictures in U.S.

A U.S. Army soldier with the 2nd Armored Brigade Combat Team, 1st Infantry Division immunizes Jacklina Mendez with the COVID-19 vaccine on March 9, 2021 on the north campus of Miami Dade College in North Miami, Florida.

Joe Raedle | Getty Images

The Biden government will allow a wider range of medical professionals, including dentists, veterinarians, paramedics and medical students, to administer Covid-19 shots to bring the nation closer to normal by midsummer.

The U.S. Department of Health is using its powers under the Public Preparedness and Emergency Preparedness Act to empower more healthcare professionals and qualified students to manage the admissions, the agency said in a statement Friday.

That means dentists, paramedics, midwives, opticians, paramedics, medical assistants, podiatrists, respiratory therapists and veterinarians can start giving Covid-19 vaccines nationwide, according to HHS.

It also empowers “medical students, nursing students and other health care students in the professions listed in the PREP Act with appropriate training and professional supervision to act as vaccines,” the statement said.

The move comes after President Joe Biden announced Thursday night that he would instruct all U.S. states, tribes, and territories to qualify all adults ages 18 and older for the coronavirus vaccines by May 1.

The president, during his first prime-time address to the nation on the one-year anniversary of the pandemic, said the goal was for Americans to gather in small, face-to-face groups to celebrate July Fourth.

“That doesn’t mean everyone gets a shot right away, but May 1st is the date that any adult can sign up to get the shot,” Biden’s Covid Tsar Jeff Zients said at a press conference on Friday. “We expect an adequate vaccine supply for all adults in this country by the end of May.”

The US currently delivers an average of 2.2 million vaccines per day per week. About 65% of Americans age 65 and over are now vaccinated, Zients said. Only more than a quarter of adults 18 and older have received at least one vaccine, according to the latest data from the Centers for Disease Control and Prevention.

“We are making progress, but there is still a lot to be done,” he said.

On Monday, the CDC released its first guidelines for people who are fully vaccinated. These state that they can now converse with other vaccinated individuals inside without masks or social distancing.

Categories
Health

President Biden Takes 1st Tentative Steps to Deal with International Covid-19 Vaccine Scarcity

WASHINGTON – President Biden was under heavy pressure on Friday to donate excess coronavirus vaccines to nations in need to otherwise address global shortages and partnered with Japan, India and Australia to increase global manufacturing capabilities Expand vaccines.

In an agreement announced at the so-called Quad Summit, a virtual meeting of the heads of state and government of the four countries, the Biden government pledged to provide financial support to enable Biological E, a large vaccine manufacturer in India, to manufacture at least 1 Billion doses of coronavirus to help vaccines by the end of 2022.

This would fix acute vaccine shortages in Southeast Asia and beyond without risking the domestic setback of exporting cans in the coming months as Americans demand their shots.

The United States has fallen far behind China, India and Russia in the race to adopt coronavirus vaccines as an instrument of diplomacy. At the same time, Mr Biden is accused of hoarding vaccines from global health lawyers who want his government to route supplies to nations in need desperately seeking access.

The president insisted that Americans come first and has so far refused to make any specific commitments to free US-made vaccines, despite tens of millions of doses of the British-Swedish company AstraZeneca’s vaccine idling in American manufacturing facilities .

“If we have a surplus, we will share it with the rest of the world,” Biden said this week, adding, “We will first make sure that the Americans are taken care of first, but then we will try the rest of the world to help. “

In fact, the president still has a lot of work to do domestically to keep the promises made in the past few days: All states must question all adults for vaccinations by May 1st so that enough vaccine doses are available by the end of May to vaccinate every American adult, and that by July 4th, if Americans continue to follow public health guidelines, life should return to a semblance of normalcy.

Vaccine supplies seem on track to meet these goals, but the president still needs to put in place the infrastructure to manage the doses and overcome reluctance in large parts of the population to take them.

Still, Mr Biden has also made restoring US leadership a core part of his foreign policy agenda after his predecessor’s alliances frayed and relations with allies and global partners strained. His Foreign Secretary, Antony J. Blinken, said in a recent BBC interview that a global vaccination campaign would be part of this effort. Washington is “determined” to be an “international leader” in vaccinations.

Foreign policy experts and global health activists see clear diplomatic, public and humanitarian reasons for this.

“It’s time for US leaders to ask themselves: When this pandemic is over, do we want the world to remember America’s leadership in helping distribute life-saving vaccines, or will we leave that to others?” said Tom Hart, the North American executive director of One Campaign, a nonprofit founded by U2 singer Bono and dedicated to eradicating global poverty.

The federal government has bought 453 million surplus doses of vaccine, the group says. She has asked the Biden administration to share 5 percent of their doses overseas when 20 percent of Americans have been vaccinated, and gradually increase the percentage of divided doses as more Americans receive their vaccines.

According to the Centers for Disease Control and Prevention, 13.5 percent of people in the United States who are 18 years of age or older were fully vaccinated as of Friday.

The authoritarian governments of China and Russia, less affected by national public opinion, are already using vaccines to expand their sphere of influence. As the Biden government plans its strategy to counter China’s growing global clout, Beijing is polishing its image by shipping vaccines to dozens of countries on multiple continents, including Africa, Latin America, and the Southeast Asian backyard in particular.

Russia has been providing vaccines to Eastern European countries like Hungary, the Czech Republic and Slovakia at a time when Biden officials want to unify the European Union against Russian influence on the continent.

“We may be outdone by others who are more willing to share, even if they do so for cynical reasons,” said Ivo H. Daalder, former NATO ambassador and president of the Chicago Council on Global Affairs. “I think countries will remember who was there for us when we needed them.”

Updated

March 13, 2021, 3:49 p.m. ET

In the face of worrying and highly contagious new varieties in the US and around the world, public health experts say vaccinating people overseas is necessary to protect Americans too.

“It has to be sold to Americans to keep Americans safe over the long term, and it has to be sold to a highly divided, toxic America,” said J. Stephen Morrison, a global health expert with Centers for Strategic and International Studies. “I don’t think that’s impossible. I think Americans are beginning to understand that in a world of variation, anything that happens outside of our borders increases the urgency to act really quickly. “

Mr Blinken also said this to the BBC: “Until everyone in the world is vaccinated, nobody is really completely safe.”

The quad vaccine partnership announced at the summit on Friday includes different commitments from each of the nations, according to the White House.

In addition to supporting the Indian vaccine maker, the US has pledged at least $ 100 million to bolster vaccination capacity overseas and support public health efforts. Japan is “in discussion” to provide loans to the Indian government to expand the production of vaccines for export and will support vaccination programs for developing countries. Australia will allocate $ 77 million for vaccine provision and delivery assistance with a focus on Southeast Asia.

The four countries will also form oneQuad Vaccine Experts Group byTop scientists and government officials who will work to overcome production hurdles and funding plans.

Mr Morrison said the government deserves “some credit” for the effort, adding, “It shows diplomatic ingenuity and speed.” However, a spokesman for One Campaign, which focuses on extreme poverty, said his group would still see a plan for the United States’ vaccine supply, noting that Africa had given far fewer doses per capita than Asia.

Mr Biden’s efforts to ramp up vaccine production helped the United States produce up to a billion doses by the end of the year – far more than needed to vaccinate the roughly 260 million adults in the United States.

What you need to know about the vaccine rollout

A government-brokered deal to see drug company Merck manufacture Johnson & Johnson’s single-dose vaccine, which the president celebrated in the White House on Wednesday, will help achieve that goal. Also on Wednesday, Mr Biden directed federal health officials to source an additional 100 million doses of the vaccine from Johnson & Johnson.

The government has stated that these efforts are aimed at having enough vaccines for children, booster doses, to face new varieties and unforeseen events. Jeffrey D. Zients, Mr Biden’s coronavirus response coordinator, told reporters Friday that the Johnson & Johnson-Merck deal would also “expand capacity and ultimately benefit the world”.

Not only did Mr Biden resist the urge to dump excess doses, but he also criticized the Liberal Democrats for blocking a motion by India and South Africa for a temporary waiver of an international intellectual property agreement that would make it easier for poorer countries to access generic versions of Coronavirus vaccines and treatments.

“I understand why we should prioritize our supply to Americans – it was paid for by American taxpayers, President Biden is President of America,” said Representative Ro Khanna, a Liberal Democrat from California. “But there is no reason to prioritize the profits of pharmaceutical companies over the dignity of other countries.”

Mr Biden recently announced a $ 4 billion donation to Covax, the international vaccine initiative supported by the World Health Organization. David Bryden, director of the Frontline Health Workers Coalition, a nonprofit that supports health workers in low- and middle-income countries, said money was also urgently needed to train and pay these workers to administer vaccines overseas.

However, that donation and the Quad’s announcement of financial support for vaccine production on Friday fell short of the urgent demands of public health advocates for the United States to provide ready-to-use doses that can be quickly injected.

However, the quad’s focus on Southeast Asia most likely reflects an awareness of China’s gratitude in the region for Beijing’s focus in its vaccine distribution efforts.

If Mr Biden is widely viewed as helping the world recover from the coronavirus pandemic, that could become part of his legacy when President George W. Bush made a huge investment in public health funding in the 2000s the AIDS crisis in Africa responded. More than a decade later, Bush and the United States continue to be revered across much of the continent for the President’s Emergency Plan for AIDS Relief (Pepfar), which the government said has spent $ 85 billion and saved 20 million lives.

Michael Gerson, a former Bush White House speechwriter and policy advisor who helped shape the Pepfar program, said its impact has been both moral and strategic and that the program has been “an enormous amount of money to the United States.” goodwill “in Africa.

“I think the principle here should be that the people who need it most should get it, no matter where they live,” he said. “There is little moral sense in giving the vaccine to a healthy American 24-year-old in front of a front-line worker in Liberia.”

But he added, “It’s very difficult for an American politician to explain.”

Ana Swanson contributed to the coverage

Categories
Health

Elizabeth Holmes trial probably delayed as a result of she’s pregnant

Elizabeth Holmes, founder and former executive director of Theranos, arrives for a hearing in the U.S. District Court in the Federal Building of Robert F. Peckham in San Jose, California on Monday, November 4, 2019.

Yichuan Cao | NurPhoto | Getty Images

Former Theranos CEO Elizabeth Holmes, whose criminal trial is due to begin in July, is asking for a delay because she is pregnant.

In a trial on Friday, her defense attorneys and prosecutors asked Judge Edward Davila to postpone the start of her trial for six weeks to begin August 31, 2021.

“On March 2, 2021, the defendant’s attorney notified the government that the defendant is pregnant and is expected to be due in July 2021,” Holmes prosecutors and attorneys write. “Both parties agree that in view of this development it is not possible to start the process on July 13, 2021.”

Further details were not immediately available.

The process has already been postponed three times due to the Covid-19 pandemic.

Holmes’ legal team was ready to address the issue of mental health as part of their defense strategy. In a previous court case, Holmes’ attorneys wrote that they intend to produce evidence “relating to a mental illness or a mental defect or other psychological condition of the defendant relating to the subject of guilt”.

This would be the expert testimony of Dr. Mindy Mechanic, a professor of clinical psychology at California State University Fullerton, who, according to the university’s website, “focuses on the psychosocial consequences of violence, trauma and victimization, with an emphasis on violence against women and other forms of violence interpersonal violence. “

The judge gave federal prosecutors the opportunity to self-examine Holmes’ mental health and to be examined by two experts, a psychologist and a psychiatrist.

Holmes and her former COO Sunny Balwani each face a dozen charges of fraud and 20 years in prison for falsely claiming that Theranos technology can perform dozens of blood tests on just a drop or two of blood.

The Silicon Valley startup was once valued at $ 9 billion before it closed in 2018.